17.1 Local Anesthetic Techniques, Complications, and Nitrous Oxide Sedation

8.1 Local Anesthetic Techniques, Complications, and Nitrous Oxide Sedation

Local anesthesia and conscious sedation form the foundation of pain control and patient management in oral and maxillofacial surgery. On the INBDE, candidates must possess a thorough understanding of cranial nerve anatomy, target injection sites, specific technique modifications, local anesthetic complications, and the precise pharmacodynamics of nitrous oxide ($N_2O$) sedation.

---

Mandibular and Maxillary Local Anesthesia Injection Techniques

Successful local anesthesia requires precise anatomical landmark identification. Because the mandibular cortical plate is dense, infiltration anesthesia is generally ineffective in the adult mandible (except for the anterior incisor region), making nerve blocks essential.

Inferior Alveolar Nerve Block (IANB)

The Inferior Alveolar Nerve Block (IANB) is the most frequently administered mandibular injection. It anesthetizes the inferior alveolar nerve, incisive nerve, mental nerve, and (via local diffusion) the lingual nerve.

• Anatomical Landmarks: Coronoid notch (greatest convexity of the anterior border of the ramus), pterygomandibular raphe, and the mandibular occlusal plane.
• Injection Height: 6 to 10 mm superior to the mandibular occlusal plane.
• Needle Insertion & Syringe Position: The syringe barrel rests over the contralateral premolars. The needle penetrates the mucosa at the intersection of a horizontal line through the coronoid notch and a vertical line through the deepest part of the pterygomandibular raphe.
• Depth of Insertion: 20 to 25 mm (approximately 2/3 to 3/4 the length of a standard 25-gauge or 27-gauge long needle) until gentle contact with bone (the medial ramus, superior to the mandibular foramen) is made.

INBDE High-Yield Landmark Rule: If bone is contacted prematurely (<15 mm), the needle tip is positioned too far anteriorly on the ramus; redirect the syringe more anteriorly over the incisors. If bone is NOT contacted (>25 mm), the needle tip is too far posteriorly; withdraw slightly and redirect the syringe more posteriorly over the contralateral molars.

• Long Buccal Nerve Block: The IANB does not anesthetize the soft tissue buccal to the mandibular molars. A separate long buccal nerve block is required, depositing anesthetic into the mucogingival junction immediately anterior/buccal to the most distal mandibular molar.

Alternative Mandibular Blocks: Gow-Gates and Vazirani-Akinosi

When anatomical variations or severe trismus limit the predictability of the standard IANB, alternative mandibular nerve blocks are indicated:

Maxillary Local Anesthetic Techniques

Due to the porous nature of the maxillary alveolar bone, local infiltration (supraperiosteal injection) is effective for most single-tooth procedures. However, quadrant dentistry requires regional nerve blocks:

• Posterior Superior Alveolar (PSA) Block: Target is the PSA nerve at the posterior surface of the maxillary tuberosity. Anesthetizes maxillary 1st, 2nd, and 3rd molars. Clinical Caveat: In 28% of the population, the mesiobuccal root of the maxillary 1st molar is innervated by the Middle Superior Alveolar (MSA) nerve and will not be anesthetized by a PSA block alone.
• PSA Complication Risk: Over-penetration of the needle (greater than 16 mm in an adult) posteriorly into the infratemporal fossa can puncture the pterygoid venous plexus or maxillary artery, causing rapid extraoral hematoma formation and facial swelling.
• Anterior Superior Alveolar (ASA / Infraorbital) Block: Target is the infraorbital foramen. Anesthetizes maxillary central incisor through canine, buccal periodontium, upper lip, and lateral nose.
• Palatal Blocks:
  • Greater Palatine Block: Injected at the greater palatine foramen (distal to maxillary 2nd molar). Anesthetizes posterior hard palate and soft tissues up to the canine region.
  • Nasopalatine Block: Injected into the incisive foramen beneath the incisive papilla. Anesthetizes palatal tissues from canine-to-canine bilaterally. Highly painful due to dense adherent mucosa.

---

Local Anesthesia Complications & Management

Complications resulting from local anesthetic administration range from mild localized tissue trauma to severe systemic neuro-vascular disturbances.

Needle Breakage

Needle breakage is an uncommon but serious complication occurring almost exclusively in the pterygomandibular space during IANB administration.

• Etiology: Primary risk factors include using 30-gauge long needles for IANB, pre-bending the needle at the hub prior to insertion, and sudden, unexpected patient movement during injection.
• Prevention & Management: Never insert a needle to its hub (the junction of the shaft and hub is the weakest point). If a needle breaks and a fragment protrudes into the oral cavity, immediately grasp it with a Hemostat and retrieve it. If the fragment is lost beneath the mucosa, instruct the patient not to move or chew, and refer immediately to an oral surgeon for radiographic localization (CBCT) and surgical removal.

Lingual Nerve Paresthesia

Paresthesia is defined as persistent altered sensation (numbness, burning, tingling, or dysesthesia) beyond the expected duration of the local anesthetic.

• Nerve Vulnerability: The lingual nerve accounts for approximately 70% of reported local anesthesia-induced paresthesias, while the inferior alveolar nerve accounts for ~25%. The lingual nerve is more vulnerable because it is fixed within the pterygomandibular space and lacks a protective osseous canal.
• Associated Agents: Clinical evidence demonstrates a higher relative incidence of paresthesia following injections with 4% Articaine and 4% Prilocaine, likely secondary to neurotoxicity from higher drug concentrations.

Transient Facial Nerve (CN VII) Paralysis

Transient facial nerve paralysis is caused by accidental deposition of local anesthetic solution into the capsule of the parotid gland during an IANB.

• Mechanism: Occurs when the needle tip is directed too far posteriorly and bone contact is not made prior to injecting. The anesthetic diffuses through the parotid capsule, producing a motor blockade of the terminal branches of the Facial Nerve (CN VII).
• Clinical Signs: Immediate loss of motor function on the affected side of the face, including inability to close the eyelid (lagophthalmos), drooping of the corner of the mouth, and loss of the nasolabial fold.
• Management Protocol: Reassure the patient that paralysis is temporary and will resolve completely as the anesthetic wears off (typically 1 to 3 hours). Remove contact lenses and apply an eye patch or lubricating eye drops to protect the cornea from drying and abrasion while corneal blink reflexes are absent.

---

Nitrous Oxide ($N_2O$) Conscious Sedation Pharmacology & Guidelines

Nitrous oxide ($N_2O-O_2$) conscious sedation is a safe, effective inhalation agent widely utilized to manage mild-to-moderate dental anxiety and elevate pain thresholds.

Pharmacological Properties

• Minimum Alveolar Concentration (MAC): The MAC of nitrous oxide is 104%. Because a MAC >100% cannot be achieved under standard atmospheric pressure (1 atm), nitrous oxide is a weak general anesthetic and cannot reliably produce surgical anesthesia when used alone at non-hypoxic concentrations.
• Blood-Gas Solubility Coefficient: $N_2O$ has an exceptionally low blood-gas solubility coefficient of 0.47. Because it dissolves poorly in blood, saturation of the blood occurs rapidly, resulting in rapid clinical onset (2 to 3 minutes) and rapid wash-out/recovery upon discontinuation.

Clinical Administration & Titration Protocol

1. Pre-oxygenation: Begin by administering 100% $O_2$ for 2 to 3 minutes at a flow rate tailored to the patient's minute volume (typically 5 to 7 L/min for adults).
2. Titration: Introduce $N_2O$ in incremental steps of 10% to 15% every 60 to 90 seconds while monitoring patient response. Ideal clinical conscious sedation is achieved at concentrations between 30% and 50% $N_2O$.
3. Clinical Signs of Proper Sedation: Patient remains conscious, responsive to verbal commands, relaxed, with reported sensations of warmth, tingling in hands/feet, and light-headedness.

INBDE High-Yield Limit: The concentration of $N_2O$ must never exceed 70% to avoid hypoxic mixture delivery ($O_2$ concentration must always remain $\ge 30%$).

Diffusion Hypoxia & Post-Procedure Oxygen Flush

When $N_2O$ administration is terminated abruptly, $N_2O$ rapidly diffuses out of the pulmonary capillaries back into the alveoli down a steep concentration gradient. This massive influx of $N_2O$ dilutes the oxygen and carbon dioxide concentration within the alveoli, resulting in diffusion hypoxia.

• Clinical Manifestations: Post-sedation headache, lethargy, nausea, disorientation, and hypoxia.
• Prevention Protocol: At the completion of the procedure, administer 100% $O_2$ for 3 to 5 minutes to flush residual $N_2O$ from the lungs and blood stream completely.

Contraindications for Nitrous Oxide Sedation